Global COVID-19 Vaccine Development Tools Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 111

Published Date: 13 Jan 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global COVID-19 Vaccine Development Tools market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global COVID-19 Vaccine Development Tools market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global COVID-19 Vaccine Development Tools market size and forecasts, in consumption value ($ Million), 2018-2029
Global COVID-19 Vaccine Development Tools market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global COVID-19 Vaccine Development Tools market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global COVID-19 Vaccine Development Tools market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for COVID-19 Vaccine Development Tools
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global COVID-19 Vaccine Development Tools market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Pfizer Inc, Celerion, Cole-Parmer Instrument Company and STEMCELL Technologies, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
COVID-19 Vaccine Development Tools market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Flow Cytometry
    Electron Microscopy
    Spectrometry
    Others

Market segment by Application
    Pharmaceutical Company
    Biotechnology Company

Market segment by players, this report covers
    Thermo Fisher Scientific
    Pfizer Inc
    Celerion
    Cole-Parmer Instrument Company
    STEMCELL Technologies
    Illumina, Inc
    AB Sciex Private Limited
    Agilent Technologies
    Danaher Corporation
    Bio-Rad Laboratories
    Qiagen NV
    Merck KgaA
    Shimadzu Corporation
    PerkinElmer Inc
    Eurofins Scientific
    Aurora Biomed
    Sartorius AG

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe COVID-19 Vaccine Development Tools product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of COVID-19 Vaccine Development Tools, with revenue, gross margin and global market share of COVID-19 Vaccine Development Tools from 2018 to 2023.
Chapter 3, the COVID-19 Vaccine Development Tools competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and COVID-19 Vaccine Development Tools market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of COVID-19 Vaccine Development Tools.
Chapter 13, to describe COVID-19 Vaccine Development Tools research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of COVID-19 Vaccine Development Tools
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of COVID-19 Vaccine Development Tools by Type
        1.3.1 Overview: Global COVID-19 Vaccine Development Tools Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global COVID-19 Vaccine Development Tools Consumption Value Market Share by Type in 2022
        1.3.3 Flow Cytometry
        1.3.4 Electron Microscopy
        1.3.5 Spectrometry
        1.3.6 Others
    1.4 Global COVID-19 Vaccine Development Tools Market by Application
        1.4.1 Overview: Global COVID-19 Vaccine Development Tools Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Pharmaceutical Company
        1.4.3 Biotechnology Company
    1.5 Global COVID-19 Vaccine Development Tools Market Size & Forecast
    1.6 Global COVID-19 Vaccine Development Tools Market Size and Forecast by Region
        1.6.1 Global COVID-19 Vaccine Development Tools Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global COVID-19 Vaccine Development Tools Market Size by Region, (2018-2029)
        1.6.3 North America COVID-19 Vaccine Development Tools Market Size and Prospect (2018-2029)
        1.6.4 Europe COVID-19 Vaccine Development Tools Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific COVID-19 Vaccine Development Tools Market Size and Prospect (2018-2029)
        1.6.6 South America COVID-19 Vaccine Development Tools Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa COVID-19 Vaccine Development Tools Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Thermo Fisher Scientific
        2.1.1 Thermo Fisher Scientific Details
        2.1.2 Thermo Fisher Scientific Major Business
        2.1.3 Thermo Fisher Scientific COVID-19 Vaccine Development Tools Product and Solutions
        2.1.4 Thermo Fisher Scientific COVID-19 Vaccine Development Tools Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
    2.2 Pfizer Inc
        2.2.1 Pfizer Inc Details
        2.2.2 Pfizer Inc Major Business
        2.2.3 Pfizer Inc COVID-19 Vaccine Development Tools Product and Solutions
        2.2.4 Pfizer Inc COVID-19 Vaccine Development Tools Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Pfizer Inc Recent Developments and Future Plans
    2.3 Celerion
        2.3.1 Celerion Details
        2.3.2 Celerion Major Business
        2.3.3 Celerion COVID-19 Vaccine Development Tools Product and Solutions
        2.3.4 Celerion COVID-19 Vaccine Development Tools Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Celerion Recent Developments and Future Plans
    2.4 Cole-Parmer Instrument Company
        2.4.1 Cole-Parmer Instrument Company Details
        2.4.2 Cole-Parmer Instrument Company Major Business
        2.4.3 Cole-Parmer Instrument Company COVID-19 Vaccine Development Tools Product and Solutions
        2.4.4 Cole-Parmer Instrument Company COVID-19 Vaccine Development Tools Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Cole-Parmer Instrument Company Recent Developments and Future Plans
    2.5 STEMCELL Technologies
        2.5.1 STEMCELL Technologies Details
        2.5.2 STEMCELL Technologies Major Business
        2.5.3 STEMCELL Technologies COVID-19 Vaccine Development Tools Product and Solutions
        2.5.4 STEMCELL Technologies COVID-19 Vaccine Development Tools Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 STEMCELL Technologies Recent Developments and Future Plans
    2.6 Illumina, Inc
        2.6.1 Illumina, Inc Details
        2.6.2 Illumina, Inc Major Business
        2.6.3 Illumina, Inc COVID-19 Vaccine Development Tools Product and Solutions
        2.6.4 Illumina, Inc COVID-19 Vaccine Development Tools Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Illumina, Inc Recent Developments and Future Plans
    2.7 AB Sciex Private Limited
        2.7.1 AB Sciex Private Limited Details
        2.7.2 AB Sciex Private Limited Major Business
        2.7.3 AB Sciex Private Limited COVID-19 Vaccine Development Tools Product and Solutions
        2.7.4 AB Sciex Private Limited COVID-19 Vaccine Development Tools Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 AB Sciex Private Limited Recent Developments and Future Plans
    2.8 Agilent Technologies
        2.8.1 Agilent Technologies Details
        2.8.2 Agilent Technologies Major Business
        2.8.3 Agilent Technologies COVID-19 Vaccine Development Tools Product and Solutions
        2.8.4 Agilent Technologies COVID-19 Vaccine Development Tools Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Agilent Technologies Recent Developments and Future Plans
    2.9 Danaher Corporation
        2.9.1 Danaher Corporation Details
        2.9.2 Danaher Corporation Major Business
        2.9.3 Danaher Corporation COVID-19 Vaccine Development Tools Product and Solutions
        2.9.4 Danaher Corporation COVID-19 Vaccine Development Tools Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Danaher Corporation Recent Developments and Future Plans
    2.10 Bio-Rad Laboratories
        2.10.1 Bio-Rad Laboratories Details
        2.10.2 Bio-Rad Laboratories Major Business
        2.10.3 Bio-Rad Laboratories COVID-19 Vaccine Development Tools Product and Solutions
        2.10.4 Bio-Rad Laboratories COVID-19 Vaccine Development Tools Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Bio-Rad Laboratories Recent Developments and Future Plans
    2.11 Qiagen NV
        2.11.1 Qiagen NV Details
        2.11.2 Qiagen NV Major Business
        2.11.3 Qiagen NV COVID-19 Vaccine Development Tools Product and Solutions
        2.11.4 Qiagen NV COVID-19 Vaccine Development Tools Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Qiagen NV Recent Developments and Future Plans
    2.12 Merck KgaA
        2.12.1 Merck KgaA Details
        2.12.2 Merck KgaA Major Business
        2.12.3 Merck KgaA COVID-19 Vaccine Development Tools Product and Solutions
        2.12.4 Merck KgaA COVID-19 Vaccine Development Tools Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Merck KgaA Recent Developments and Future Plans
    2.13 Shimadzu Corporation
        2.13.1 Shimadzu Corporation Details
        2.13.2 Shimadzu Corporation Major Business
        2.13.3 Shimadzu Corporation COVID-19 Vaccine Development Tools Product and Solutions
        2.13.4 Shimadzu Corporation COVID-19 Vaccine Development Tools Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Shimadzu Corporation Recent Developments and Future Plans
    2.14 PerkinElmer Inc
        2.14.1 PerkinElmer Inc Details
        2.14.2 PerkinElmer Inc Major Business
        2.14.3 PerkinElmer Inc COVID-19 Vaccine Development Tools Product and Solutions
        2.14.4 PerkinElmer Inc COVID-19 Vaccine Development Tools Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 PerkinElmer Inc Recent Developments and Future Plans
    2.15 Eurofins Scientific
        2.15.1 Eurofins Scientific Details
        2.15.2 Eurofins Scientific Major Business
        2.15.3 Eurofins Scientific COVID-19 Vaccine Development Tools Product and Solutions
        2.15.4 Eurofins Scientific COVID-19 Vaccine Development Tools Revenue, Gross Margin and Market Share (2018-2023)
        2.15.5 Eurofins Scientific Recent Developments and Future Plans
    2.16 Aurora Biomed
        2.16.1 Aurora Biomed Details
        2.16.2 Aurora Biomed Major Business
        2.16.3 Aurora Biomed COVID-19 Vaccine Development Tools Product and Solutions
        2.16.4 Aurora Biomed COVID-19 Vaccine Development Tools Revenue, Gross Margin and Market Share (2018-2023)
        2.16.5 Aurora Biomed Recent Developments and Future Plans
    2.17 Sartorius AG
        2.17.1 Sartorius AG Details
        2.17.2 Sartorius AG Major Business
        2.17.3 Sartorius AG COVID-19 Vaccine Development Tools Product and Solutions
        2.17.4 Sartorius AG COVID-19 Vaccine Development Tools Revenue, Gross Margin and Market Share (2018-2023)
        2.17.5 Sartorius AG Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global COVID-19 Vaccine Development Tools Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of COVID-19 Vaccine Development Tools by Company Revenue
        3.2.2 Top 3 COVID-19 Vaccine Development Tools Players Market Share in 2022
        3.2.3 Top 6 COVID-19 Vaccine Development Tools Players Market Share in 2022
    3.3 COVID-19 Vaccine Development Tools Market: Overall Company Footprint Analysis
        3.3.1 COVID-19 Vaccine Development Tools Market: Region Footprint
        3.3.2 COVID-19 Vaccine Development Tools Market: Company Product Type Footprint
        3.3.3 COVID-19 Vaccine Development Tools Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global COVID-19 Vaccine Development Tools Consumption Value and Market Share by Type (2018-2023)
    4.2 Global COVID-19 Vaccine Development Tools Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global COVID-19 Vaccine Development Tools Consumption Value Market Share by Application (2018-2023)
    5.2 Global COVID-19 Vaccine Development Tools Market Forecast by Application (2024-2029)

6 North America
    6.1 North America COVID-19 Vaccine Development Tools Consumption Value by Type (2018-2029)
    6.2 North America COVID-19 Vaccine Development Tools Consumption Value by Application (2018-2029)
    6.3 North America COVID-19 Vaccine Development Tools Market Size by Country
        6.3.1 North America COVID-19 Vaccine Development Tools Consumption Value by Country (2018-2029)
        6.3.2 United States COVID-19 Vaccine Development Tools Market Size and Forecast (2018-2029)
        6.3.3 Canada COVID-19 Vaccine Development Tools Market Size and Forecast (2018-2029)
        6.3.4 Mexico COVID-19 Vaccine Development Tools Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe COVID-19 Vaccine Development Tools Consumption Value by Type (2018-2029)
    7.2 Europe COVID-19 Vaccine Development Tools Consumption Value by Application (2018-2029)
    7.3 Europe COVID-19 Vaccine Development Tools Market Size by Country
        7.3.1 Europe COVID-19 Vaccine Development Tools Consumption Value by Country (2018-2029)
        7.3.2 Germany COVID-19 Vaccine Development Tools Market Size and Forecast (2018-2029)
        7.3.3 France COVID-19 Vaccine Development Tools Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom COVID-19 Vaccine Development Tools Market Size and Forecast (2018-2029)
        7.3.5 Russia COVID-19 Vaccine Development Tools Market Size and Forecast (2018-2029)
        7.3.6 Italy COVID-19 Vaccine Development Tools Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific COVID-19 Vaccine Development Tools Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific COVID-19 Vaccine Development Tools Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific COVID-19 Vaccine Development Tools Market Size by Region
        8.3.1 Asia-Pacific COVID-19 Vaccine Development Tools Consumption Value by Region (2018-2029)
        8.3.2 China COVID-19 Vaccine Development Tools Market Size and Forecast (2018-2029)
        8.3.3 Japan COVID-19 Vaccine Development Tools Market Size and Forecast (2018-2029)
        8.3.4 South Korea COVID-19 Vaccine Development Tools Market Size and Forecast (2018-2029)
        8.3.5 India COVID-19 Vaccine Development Tools Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia COVID-19 Vaccine Development Tools Market Size and Forecast (2018-2029)
        8.3.7 Australia COVID-19 Vaccine Development Tools Market Size and Forecast (2018-2029)

9 South America
    9.1 South America COVID-19 Vaccine Development Tools Consumption Value by Type (2018-2029)
    9.2 South America COVID-19 Vaccine Development Tools Consumption Value by Application (2018-2029)
    9.3 South America COVID-19 Vaccine Development Tools Market Size by Country
        9.3.1 South America COVID-19 Vaccine Development Tools Consumption Value by Country (2018-2029)
        9.3.2 Brazil COVID-19 Vaccine Development Tools Market Size and Forecast (2018-2029)
        9.3.3 Argentina COVID-19 Vaccine Development Tools Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa COVID-19 Vaccine Development Tools Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa COVID-19 Vaccine Development Tools Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa COVID-19 Vaccine Development Tools Market Size by Country
        10.3.1 Middle East & Africa COVID-19 Vaccine Development Tools Consumption Value by Country (2018-2029)
        10.3.2 Turkey COVID-19 Vaccine Development Tools Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia COVID-19 Vaccine Development Tools Market Size and Forecast (2018-2029)
        10.3.4 UAE COVID-19 Vaccine Development Tools Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 COVID-19 Vaccine Development Tools Market Drivers
    11.2 COVID-19 Vaccine Development Tools Market Restraints
    11.3 COVID-19 Vaccine Development Tools Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 COVID-19 Vaccine Development Tools Industry Chain
    12.2 COVID-19 Vaccine Development Tools Upstream Analysis
    12.3 COVID-19 Vaccine Development Tools Midstream Analysis
    12.4 COVID-19 Vaccine Development Tools Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global COVID-19 Vaccine Development Tools Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global COVID-19 Vaccine Development Tools Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global COVID-19 Vaccine Development Tools Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global COVID-19 Vaccine Development Tools Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
    Table 6. Thermo Fisher Scientific Major Business
    Table 7. Thermo Fisher Scientific COVID-19 Vaccine Development Tools Product and Solutions
    Table 8. Thermo Fisher Scientific COVID-19 Vaccine Development Tools Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Thermo Fisher Scientific Recent Developments and Future Plans
    Table 10. Pfizer Inc Company Information, Head Office, and Major Competitors
    Table 11. Pfizer Inc Major Business
    Table 12. Pfizer Inc COVID-19 Vaccine Development Tools Product and Solutions
    Table 13. Pfizer Inc COVID-19 Vaccine Development Tools Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Pfizer Inc Recent Developments and Future Plans
    Table 15. Celerion Company Information, Head Office, and Major Competitors
    Table 16. Celerion Major Business
    Table 17. Celerion COVID-19 Vaccine Development Tools Product and Solutions
    Table 18. Celerion COVID-19 Vaccine Development Tools Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Celerion Recent Developments and Future Plans
    Table 20. Cole-Parmer Instrument Company Company Information, Head Office, and Major Competitors
    Table 21. Cole-Parmer Instrument Company Major Business
    Table 22. Cole-Parmer Instrument Company COVID-19 Vaccine Development Tools Product and Solutions
    Table 23. Cole-Parmer Instrument Company COVID-19 Vaccine Development Tools Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Cole-Parmer Instrument Company Recent Developments and Future Plans
    Table 25. STEMCELL Technologies Company Information, Head Office, and Major Competitors
    Table 26. STEMCELL Technologies Major Business
    Table 27. STEMCELL Technologies COVID-19 Vaccine Development Tools Product and Solutions
    Table 28. STEMCELL Technologies COVID-19 Vaccine Development Tools Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. STEMCELL Technologies Recent Developments and Future Plans
    Table 30. Illumina, Inc Company Information, Head Office, and Major Competitors
    Table 31. Illumina, Inc Major Business
    Table 32. Illumina, Inc COVID-19 Vaccine Development Tools Product and Solutions
    Table 33. Illumina, Inc COVID-19 Vaccine Development Tools Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Illumina, Inc Recent Developments and Future Plans
    Table 35. AB Sciex Private Limited Company Information, Head Office, and Major Competitors
    Table 36. AB Sciex Private Limited Major Business
    Table 37. AB Sciex Private Limited COVID-19 Vaccine Development Tools Product and Solutions
    Table 38. AB Sciex Private Limited COVID-19 Vaccine Development Tools Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. AB Sciex Private Limited Recent Developments and Future Plans
    Table 40. Agilent Technologies Company Information, Head Office, and Major Competitors
    Table 41. Agilent Technologies Major Business
    Table 42. Agilent Technologies COVID-19 Vaccine Development Tools Product and Solutions
    Table 43. Agilent Technologies COVID-19 Vaccine Development Tools Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. Agilent Technologies Recent Developments and Future Plans
    Table 45. Danaher Corporation Company Information, Head Office, and Major Competitors
    Table 46. Danaher Corporation Major Business
    Table 47. Danaher Corporation COVID-19 Vaccine Development Tools Product and Solutions
    Table 48. Danaher Corporation COVID-19 Vaccine Development Tools Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. Danaher Corporation Recent Developments and Future Plans
    Table 50. Bio-Rad Laboratories Company Information, Head Office, and Major Competitors
    Table 51. Bio-Rad Laboratories Major Business
    Table 52. Bio-Rad Laboratories COVID-19 Vaccine Development Tools Product and Solutions
    Table 53. Bio-Rad Laboratories COVID-19 Vaccine Development Tools Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. Bio-Rad Laboratories Recent Developments and Future Plans
    Table 55. Qiagen NV Company Information, Head Office, and Major Competitors
    Table 56. Qiagen NV Major Business
    Table 57. Qiagen NV COVID-19 Vaccine Development Tools Product and Solutions
    Table 58. Qiagen NV COVID-19 Vaccine Development Tools Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. Qiagen NV Recent Developments and Future Plans
    Table 60. Merck KgaA Company Information, Head Office, and Major Competitors
    Table 61. Merck KgaA Major Business
    Table 62. Merck KgaA COVID-19 Vaccine Development Tools Product and Solutions
    Table 63. Merck KgaA COVID-19 Vaccine Development Tools Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 64. Merck KgaA Recent Developments and Future Plans
    Table 65. Shimadzu Corporation Company Information, Head Office, and Major Competitors
    Table 66. Shimadzu Corporation Major Business
    Table 67. Shimadzu Corporation COVID-19 Vaccine Development Tools Product and Solutions
    Table 68. Shimadzu Corporation COVID-19 Vaccine Development Tools Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 69. Shimadzu Corporation Recent Developments and Future Plans
    Table 70. PerkinElmer Inc Company Information, Head Office, and Major Competitors
    Table 71. PerkinElmer Inc Major Business
    Table 72. PerkinElmer Inc COVID-19 Vaccine Development Tools Product and Solutions
    Table 73. PerkinElmer Inc COVID-19 Vaccine Development Tools Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 74. PerkinElmer Inc Recent Developments and Future Plans
    Table 75. Eurofins Scientific Company Information, Head Office, and Major Competitors
    Table 76. Eurofins Scientific Major Business
    Table 77. Eurofins Scientific COVID-19 Vaccine Development Tools Product and Solutions
    Table 78. Eurofins Scientific COVID-19 Vaccine Development Tools Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 79. Eurofins Scientific Recent Developments and Future Plans
    Table 80. Aurora Biomed Company Information, Head Office, and Major Competitors
    Table 81. Aurora Biomed Major Business
    Table 82. Aurora Biomed COVID-19 Vaccine Development Tools Product and Solutions
    Table 83. Aurora Biomed COVID-19 Vaccine Development Tools Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 84. Aurora Biomed Recent Developments and Future Plans
    Table 85. Sartorius AG Company Information, Head Office, and Major Competitors
    Table 86. Sartorius AG Major Business
    Table 87. Sartorius AG COVID-19 Vaccine Development Tools Product and Solutions
    Table 88. Sartorius AG COVID-19 Vaccine Development Tools Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Sartorius AG Recent Developments and Future Plans
    Table 90. Global COVID-19 Vaccine Development Tools Revenue (USD Million) by Players (2018-2023)
    Table 91. Global COVID-19 Vaccine Development Tools Revenue Share by Players (2018-2023)
    Table 92. Breakdown of COVID-19 Vaccine Development Tools by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 93. Market Position of Players in COVID-19 Vaccine Development Tools, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 94. Head Office of Key COVID-19 Vaccine Development Tools Players
    Table 95. COVID-19 Vaccine Development Tools Market: Company Product Type Footprint
    Table 96. COVID-19 Vaccine Development Tools Market: Company Product Application Footprint
    Table 97. COVID-19 Vaccine Development Tools New Market Entrants and Barriers to Market Entry
    Table 98. COVID-19 Vaccine Development Tools Mergers, Acquisition, Agreements, and Collaborations
    Table 99. Global COVID-19 Vaccine Development Tools Consumption Value (USD Million) by Type (2018-2023)
    Table 100. Global COVID-19 Vaccine Development Tools Consumption Value Share by Type (2018-2023)
    Table 101. Global COVID-19 Vaccine Development Tools Consumption Value Forecast by Type (2024-2029)
    Table 102. Global COVID-19 Vaccine Development Tools Consumption Value by Application (2018-2023)
    Table 103. Global COVID-19 Vaccine Development Tools Consumption Value Forecast by Application (2024-2029)
    Table 104. North America COVID-19 Vaccine Development Tools Consumption Value by Type (2018-2023) & (USD Million)
    Table 105. North America COVID-19 Vaccine Development Tools Consumption Value by Type (2024-2029) & (USD Million)
    Table 106. North America COVID-19 Vaccine Development Tools Consumption Value by Application (2018-2023) & (USD Million)
    Table 107. North America COVID-19 Vaccine Development Tools Consumption Value by Application (2024-2029) & (USD Million)
    Table 108. North America COVID-19 Vaccine Development Tools Consumption Value by Country (2018-2023) & (USD Million)
    Table 109. North America COVID-19 Vaccine Development Tools Consumption Value by Country (2024-2029) & (USD Million)
    Table 110. Europe COVID-19 Vaccine Development Tools Consumption Value by Type (2018-2023) & (USD Million)
    Table 111. Europe COVID-19 Vaccine Development Tools Consumption Value by Type (2024-2029) & (USD Million)
    Table 112. Europe COVID-19 Vaccine Development Tools Consumption Value by Application (2018-2023) & (USD Million)
    Table 113. Europe COVID-19 Vaccine Development Tools Consumption Value by Application (2024-2029) & (USD Million)
    Table 114. Europe COVID-19 Vaccine Development Tools Consumption Value by Country (2018-2023) & (USD Million)
    Table 115. Europe COVID-19 Vaccine Development Tools Consumption Value by Country (2024-2029) & (USD Million)
    Table 116. Asia-Pacific COVID-19 Vaccine Development Tools Consumption Value by Type (2018-2023) & (USD Million)
    Table 117. Asia-Pacific COVID-19 Vaccine Development Tools Consumption Value by Type (2024-2029) & (USD Million)
    Table 118. Asia-Pacific COVID-19 Vaccine Development Tools Consumption Value by Application (2018-2023) & (USD Million)
    Table 119. Asia-Pacific COVID-19 Vaccine Development Tools Consumption Value by Application (2024-2029) & (USD Million)
    Table 120. Asia-Pacific COVID-19 Vaccine Development Tools Consumption Value by Region (2018-2023) & (USD Million)
    Table 121. Asia-Pacific COVID-19 Vaccine Development Tools Consumption Value by Region (2024-2029) & (USD Million)
    Table 122. South America COVID-19 Vaccine Development Tools Consumption Value by Type (2018-2023) & (USD Million)
    Table 123. South America COVID-19 Vaccine Development Tools Consumption Value by Type (2024-2029) & (USD Million)
    Table 124. South America COVID-19 Vaccine Development Tools Consumption Value by Application (2018-2023) & (USD Million)
    Table 125. South America COVID-19 Vaccine Development Tools Consumption Value by Application (2024-2029) & (USD Million)
    Table 126. South America COVID-19 Vaccine Development Tools Consumption Value by Country (2018-2023) & (USD Million)
    Table 127. South America COVID-19 Vaccine Development Tools Consumption Value by Country (2024-2029) & (USD Million)
    Table 128. Middle East & Africa COVID-19 Vaccine Development Tools Consumption Value by Type (2018-2023) & (USD Million)
    Table 129. Middle East & Africa COVID-19 Vaccine Development Tools Consumption Value by Type (2024-2029) & (USD Million)
    Table 130. Middle East & Africa COVID-19 Vaccine Development Tools Consumption Value by Application (2018-2023) & (USD Million)
    Table 131. Middle East & Africa COVID-19 Vaccine Development Tools Consumption Value by Application (2024-2029) & (USD Million)
    Table 132. Middle East & Africa COVID-19 Vaccine Development Tools Consumption Value by Country (2018-2023) & (USD Million)
    Table 133. Middle East & Africa COVID-19 Vaccine Development Tools Consumption Value by Country (2024-2029) & (USD Million)
    Table 134. COVID-19 Vaccine Development Tools Raw Material
    Table 135. Key Suppliers of COVID-19 Vaccine Development Tools Raw Materials
List of Figures
    Figure 1. COVID-19 Vaccine Development Tools Picture
    Figure 2. Global COVID-19 Vaccine Development Tools Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global COVID-19 Vaccine Development Tools Consumption Value Market Share by Type in 2022
    Figure 4. Flow Cytometry
    Figure 5. Electron Microscopy
    Figure 6. Spectrometry
    Figure 7. Others
    Figure 8. Global COVID-19 Vaccine Development Tools Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 9. COVID-19 Vaccine Development Tools Consumption Value Market Share by Application in 2022
    Figure 10. Pharmaceutical Company Picture
    Figure 11. Biotechnology Company Picture
    Figure 12. Global COVID-19 Vaccine Development Tools Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 13. Global COVID-19 Vaccine Development Tools Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 14. Global Market COVID-19 Vaccine Development Tools Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 15. Global COVID-19 Vaccine Development Tools Consumption Value Market Share by Region (2018-2029)
    Figure 16. Global COVID-19 Vaccine Development Tools Consumption Value Market Share by Region in 2022
    Figure 17. North America COVID-19 Vaccine Development Tools Consumption Value (2018-2029) & (USD Million)
    Figure 18. Europe COVID-19 Vaccine Development Tools Consumption Value (2018-2029) & (USD Million)
    Figure 19. Asia-Pacific COVID-19 Vaccine Development Tools Consumption Value (2018-2029) & (USD Million)
    Figure 20. South America COVID-19 Vaccine Development Tools Consumption Value (2018-2029) & (USD Million)
    Figure 21. Middle East and Africa COVID-19 Vaccine Development Tools Consumption Value (2018-2029) & (USD Million)
    Figure 22. Global COVID-19 Vaccine Development Tools Revenue Share by Players in 2022
    Figure 23. COVID-19 Vaccine Development Tools Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 24. Global Top 3 Players COVID-19 Vaccine Development Tools Market Share in 2022
    Figure 25. Global Top 6 Players COVID-19 Vaccine Development Tools Market Share in 2022
    Figure 26. Global COVID-19 Vaccine Development Tools Consumption Value Share by Type (2018-2023)
    Figure 27. Global COVID-19 Vaccine Development Tools Market Share Forecast by Type (2024-2029)
    Figure 28. Global COVID-19 Vaccine Development Tools Consumption Value Share by Application (2018-2023)
    Figure 29. Global COVID-19 Vaccine Development Tools Market Share Forecast by Application (2024-2029)
    Figure 30. North America COVID-19 Vaccine Development Tools Consumption Value Market Share by Type (2018-2029)
    Figure 31. North America COVID-19 Vaccine Development Tools Consumption Value Market Share by Application (2018-2029)
    Figure 32. North America COVID-19 Vaccine Development Tools Consumption Value Market Share by Country (2018-2029)
    Figure 33. United States COVID-19 Vaccine Development Tools Consumption Value (2018-2029) & (USD Million)
    Figure 34. Canada COVID-19 Vaccine Development Tools Consumption Value (2018-2029) & (USD Million)
    Figure 35. Mexico COVID-19 Vaccine Development Tools Consumption Value (2018-2029) & (USD Million)
    Figure 36. Europe COVID-19 Vaccine Development Tools Consumption Value Market Share by Type (2018-2029)
    Figure 37. Europe COVID-19 Vaccine Development Tools Consumption Value Market Share by Application (2018-2029)
    Figure 38. Europe COVID-19 Vaccine Development Tools Consumption Value Market Share by Country (2018-2029)
    Figure 39. Germany COVID-19 Vaccine Development Tools Consumption Value (2018-2029) & (USD Million)
    Figure 40. France COVID-19 Vaccine Development Tools Consumption Value (2018-2029) & (USD Million)
    Figure 41. United Kingdom COVID-19 Vaccine Development Tools Consumption Value (2018-2029) & (USD Million)
    Figure 42. Russia COVID-19 Vaccine Development Tools Consumption Value (2018-2029) & (USD Million)
    Figure 43. Italy COVID-19 Vaccine Development Tools Consumption Value (2018-2029) & (USD Million)
    Figure 44. Asia-Pacific COVID-19 Vaccine Development Tools Consumption Value Market Share by Type (2018-2029)
    Figure 45. Asia-Pacific COVID-19 Vaccine Development Tools Consumption Value Market Share by Application (2018-2029)
    Figure 46. Asia-Pacific COVID-19 Vaccine Development Tools Consumption Value Market Share by Region (2018-2029)
    Figure 47. China COVID-19 Vaccine Development Tools Consumption Value (2018-2029) & (USD Million)
    Figure 48. Japan COVID-19 Vaccine Development Tools Consumption Value (2018-2029) & (USD Million)
    Figure 49. South Korea COVID-19 Vaccine Development Tools Consumption Value (2018-2029) & (USD Million)
    Figure 50. India COVID-19 Vaccine Development Tools Consumption Value (2018-2029) & (USD Million)
    Figure 51. Southeast Asia COVID-19 Vaccine Development Tools Consumption Value (2018-2029) & (USD Million)
    Figure 52. Australia COVID-19 Vaccine Development Tools Consumption Value (2018-2029) & (USD Million)
    Figure 53. South America COVID-19 Vaccine Development Tools Consumption Value Market Share by Type (2018-2029)
    Figure 54. South America COVID-19 Vaccine Development Tools Consumption Value Market Share by Application (2018-2029)
    Figure 55. South America COVID-19 Vaccine Development Tools Consumption Value Market Share by Country (2018-2029)
    Figure 56. Brazil COVID-19 Vaccine Development Tools Consumption Value (2018-2029) & (USD Million)
    Figure 57. Argentina COVID-19 Vaccine Development Tools Consumption Value (2018-2029) & (USD Million)
    Figure 58. Middle East and Africa COVID-19 Vaccine Development Tools Consumption Value Market Share by Type (2018-2029)
    Figure 59. Middle East and Africa COVID-19 Vaccine Development Tools Consumption Value Market Share by Application (2018-2029)
    Figure 60. Middle East and Africa COVID-19 Vaccine Development Tools Consumption Value Market Share by Country (2018-2029)
    Figure 61. Turkey COVID-19 Vaccine Development Tools Consumption Value (2018-2029) & (USD Million)
    Figure 62. Saudi Arabia COVID-19 Vaccine Development Tools Consumption Value (2018-2029) & (USD Million)
    Figure 63. UAE COVID-19 Vaccine Development Tools Consumption Value (2018-2029) & (USD Million)
    Figure 64. COVID-19 Vaccine Development Tools Market Drivers
    Figure 65. COVID-19 Vaccine Development Tools Market Restraints
    Figure 66. COVID-19 Vaccine Development Tools Market Trends
    Figure 67. Porters Five Forces Analysis
    Figure 68. Manufacturing Cost Structure Analysis of COVID-19 Vaccine Development Tools in 2022
    Figure 69. Manufacturing Process Analysis of COVID-19 Vaccine Development Tools
    Figure 70. COVID-19 Vaccine Development Tools Industrial Chain
    Figure 71. Methodology
    Figure 72. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global COVID-19 Vaccine Development Tools Supply, Demand and Key Producers, 2023-2029

Global COVID-19 Vaccine Development Tools Supply, Demand and Key Producers, 2023-2029

date 04 Feb 2023

date Medical Care

The global COVID-19 Vaccine Development Tools market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Product Tags

COVID-19 Vaccine Development Tools

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>